; (B) limit work to that within its competence and capacity; (C) treat proprietary, confidential, and commercial information received, including records, reports, and recommendations, as confidential information; (D) promptly respond and attempt to resolve complaints regarding the activities for which it is accredited; and (E) protect against the use, in carrying out subsection (a) with respect to a cosmetic, of any officer or employee of the entity who has a financial conflict of interest regarding the cosmetic, and annually make available to the public disclosures of the extent to which the entity, and the officers and employees of the entity, have maintained compliance with requirements under this subparagraph relating to financial conflicts of interest. (f) Rule of Construction Nothing in this section is intended to affect the Secretary’s authority to enter into contracts with non-accredited third parties for purposes of cosmetic safety review. . 9. Reporting Chapter VI of the Federal Food, Drug, and Cosmetic Act ( 21 U.S.C. 361 et seq.), as amended by section 8, is further amended by adding at the end the following: 608. Cosmetic ingredient report (a) Annual report to Congress The Commissioner shall submit an annual report to the appropriate committees of Congress that includes a report or summary of— (1) the ingredients or non-functional constituents that the Commissioner has identified for review under section 606(a); (2) the ingredients or non-functional constituents for which the Commissioner has issued a proposed order, a final order, or a finding of incomplete evidence under section 606(b); (3) the ongoing ingredient or non-functional constituents being reviewed for safety at the time of submission of the report, reviews the Commissioner has determined to be needed, and reviews for which Commissioner is contracting with an accredited third party